NCT02734069Recruiting
Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC
Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Source: ClinicalTrials.gov · Last updated 24 Dec 2025
Brief summary (registry, in English)
This study evaluate the association of body composition (mainly free-fat mass), clinical and biochemical parameters with development of toxicity in patients under treatment with Carboplatin/Paclitaxel in advanced NSCLC.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 132 (estimated)
- First submitted
- 31 Mar 2016
- Start date
- 1 Feb 2016
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Instituto Nacional de Cancerologia de Mexico
- Diseases
- Lung cancer
- NCT number
- NCT02734069
What you commit to
- Study type: Observational
- Planned participants: 132
- From 1 Feb 2016 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with renal impairment (KDOQI 3-5)
- Uncontrolled diabetes (\> 130 mg / dL)
Other
- Patients who do not have computed tomography study at baseline
- Uncontrolled blood pressure (\> 140 mmHg)
- Obstruction in kidney (s) or ureter (s)
- Dehydrated patients
- Patients with high consumption of NSAIDs (aspirin, ibuprofen, etc.\> 1 month)
Who the study is looking for
- Diagnosis of NSCLC Stage IV (stratification according to the American Joint Committee on Cancers - 7th edition)
- Candidates for treatment with carboplatin plus paclitaxel 1st line
- Performance status (ECOG 0-2)
- Laboratory studies that demonstrate adequate renal, hepatic and hematologic function (blood chemistry and blood count)
- Normal renal ultrasound prior to initiation of treatment
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Instituto Nacional de Cancerologia Coordinator of this site? Confirm its status | Mexico City | Mexico | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.